Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infections.

The Journal of antimicrobial chemotherapy·2026
Same author

Basic Microbiome Analysis: Analytical Steps from Sampling to Sequencing.

Microorganisms·2026
Same author

Whole genome sequencing and analysis of the clinical implications of SARS-CoV-2 strains.

Journal of infection in developing countries·2025
Same author

Infectious agents, protein electrophoresis and immunoglobulin levels in patients with coronary artery ectasia.

Indian heart journal·2025
Same author

A widespread dissemination of <i>Bacillus licheniformis</i> in a tertiary hospital: an outbreak or pseudo-outbreak?

Infection control and hospital epidemiology·2025
Same author

Emerging West Nile virus infections in Türkiye.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025

Related Experiment Video

Updated: Jun 26, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[A pneumonia case caused by Cedecea lapagei].

Gülay Yetkin1, Selma Ay, Uner Kayabaş

  • 1Inönü Universitesi Tip Fakültesi, Tibbi Mikrobiyoloji Anabilim Dali, Malatya. gulayyetkin03@hotmail.com

Mikrobiyoloji Bulteni
|January 20, 2009
PubMed
Summary

This case report details the first documented instance of pneumonia caused by Cedecea lapagei, a bacterium typically found in sputum. The infection likely resulted from aspiration in an unconscious patient with chronic obstructive pulmonary disease.

Related Experiment Videos

Last Updated: Jun 26, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Cedecea species, members of the Enterobacteriaceae family, are commonly isolated from sputum but their clinical significance remains largely undetermined.
  • This report focuses on a rare case of pneumonia attributed to Cedecea lapagei.

Observation:

  • A 38-year-old male patient with a history of chronic obstructive pulmonary disease (COPD) developed pneumonia while in the Intensive Care Unit (ICU) following surgery for subarachnoid hemorrhage.
  • Clinical presentation included fever, elevated white blood cell count, and opacities on chest X-ray.
  • Bronchoalveolar lavage (BAL) revealed numerous leukocytes and gram-negative bacilli, identified as Cedecea lapagei.

Findings:

  • Cedecea lapagei was identified using automated systems (Phoenix 100) and the API 20E kit.
  • The patient received intravenous amikacin and meropenem, leading to a decrease in infection signs.
  • Despite treatment, the patient succumbed to subarachnoid hemorrhage on the 12th day of hospitalization.

Implications:

  • This case highlights Cedecea lapagei as a potential pathogen causing pneumonia, particularly in critically ill patients with impaired consciousness and risk factors like COPD.
  • The likely route of infection was aspiration of upper airway secretions.
  • This represents the first documented case of C. lapagei pneumonia in the available literature, underscoring the need for awareness of this bacterium in clinical settings.